AC
IONS icon

Allstate Corporation’s Ionis Pharmaceuticals IONS Stock Holding History

Allstate Corporation’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.54M Buy
+20,565
New +$1.62M 0.02% 619
2020
Q3 		– Sell
-3,974
Closed -$234K – 690
2020
Q2 		$234K Buy
+3,974
New +$221K 0.01% 634
2019
Q4 		– Sell
-12,110
Closed -$726K – 624
2019
Q3 		$726K Buy
12,110
+7,667
+173% +$500K 0.01% 411
2019
Q2 		$286K Buy
+4,443
New +$314K 0.01% 454

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allstate Corporation's IONS Position: Q1 2026 in Review

Allstate Corporation opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 20,565 shares worth $1.54M. The stake represents 0.02% of the portfolio and ranks #619 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in IONS as recently as Q2 2020.

Allstate Corporation first reported a position in IONS in Q2 2019 and has held it in 4 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Allstate Corporation held 20,565 shares of Ionis Pharmaceuticals worth $1.54M as of Q1 2026.
  • Ionis Pharmaceuticals was a new Allstate Corporation position in Q1 2026.
  • Ionis Pharmaceuticals made up 0.02% of Allstate Corporation's portfolio in Q1 2026, its #619 holding.
  • Allstate Corporation first reported a position in Ionis Pharmaceuticals in Q2 2019 and has held it in 4 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.